Roche Diagnostics, the market leader in India's IVD industry, has confirmed it has moved out of the insulin pumps segment in the country. According to the company, the insulin pump is not extensively used in India as a solution for people with insulin-dependency.
The Swiss multinational said it would like to "focus" on providing people with diabetes self-monitoring solutions that will help them have a "good quality of life."
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?